Magnetic Nanoparticle Assay Speed via Size Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current detection assays, such as Western blot and ELISA, are time-consuming and inefficient due to the immobilization of target molecules on substrates, which limits the speed and sensitivity of the detection process.
Innovation Solution
The use of small-diameter magnetic nanoparticles (MNPs) associated with capture molecules and applied under a magnetic field enhances the detection efficiency by allowing better infiltration into substrates and maintaining a 1:1 binding ratio, improving signal uniformity and dynamic range.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Volume of moving object
If large magnetic nanoparticles are used in detection assays, then the magnetic field can effectively concentrate the particles, but the particles cannot infiltrate into small pores of substrates effectively
Solution Approach 1:
The patent changes the size parameter of magnetic nanoparticles from conventional large sizes (≥50 nm) to small sizes (5-50 nm, preferably 10-30 nm). This parameter change enables the nanoparticles to infiltrate into small pores of substrates while still being effectively concentrated by magnetic fields, thereby resolving the contradiction between particle size and detection efficiency.
2Ease of manufacture
If target molecules are immobilized on porous substrates, then the detection can be performed using standard protocols, but the process becomes time-consuming and tedious
Solution Approach 1:
The patent replaces the conventional mechanical/chemical development process (incubation, washing, signal development taking 3-4 hours to overnight) with magnetic field-based concentration of small MNPs. The magnetic field rapidly concentrates the small MNPs bound to target molecules onto the substrate surface within minutes, eliminating the need for prolonged incubation and washing steps while maintaining protocol simplicity.
3Adaptability or versatility
If conventional large particles are used as detectable markers, then the assay can be performed as a sandwich assay, but the detection speed and efficiency are limited
Solution Approach 1:
The patent changes the size parameter of detectable markers from conventional large particles (≥50 nm) to small magnetic nanoparticles (5-50 nm). This size reduction enables rapid magnetic field concentration and infiltration into substrates, accelerating detection from hours to minutes while preserving the sandwich assay format and its versatility for various detection applications.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly accelerates the detection process, providing reliable results within minutes and enhancing the sensitivity and speed of assays like dot blot, Western blot, and ELISA, while reducing background noise and improving signal intensity.
Implementation Method 1
The fluid sample is incubated with magnetic particles coated with binding molecules directed to the analyte. The method is based on concentrating the magnetically labeled analyte to a detection region using a focusing magnet.
Implementation Method 2
magnetic particles coated with binding molecules directed to the analyte
Implementation Method 3
The small size of the MNP allows the infiltration of the particles into a substrate having small pores
Data Source
AI summary
The present invention is directed to novel assays for detecting target molecules. The assays employ small size, detectably labeled, magnetic nanoparticles associated with a capture molecule. The detection assay is accelerated by applying magnetic field during the assay. The assays of the invention can be used to enhance the efficiency of the detection step in dot blot, Western blot and ELISA.